Utility of discovery approach using proteomics to create a biomarker profile for coronary microvascular dysfunction
ConclusionMass spectrometry using discovery approach may not be an adequate method for quantitative assessment of serum proteins in CMD patients. Future MS studies should evaluate other approaches including tissue samples or serial measurements.
Source: Microvascular Research - Category: Biochemistry Source Type: research
More News: Beta-Blockers | Biochemistry | CT Scan | Heart Attack | Lexiscan | Perfusion | PET Scan | Statistics | Study | von Willebrand Disease